October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
A broad array of contrast and injection management products for diagnostic imaging in radiology are provided with the ...
August 13, 2009 - MEDRAD has introduced an eight-piece microbore disposables set for the Continuum MR Infusion System ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
Aug 12, 2009 - The Peripheral and Central Nervous System Drugs advisory committee of the U.S. Food and Drug ...
August 3, 2009 - Cardinal Health today announced it has agreed to acquire the assets of privately held Biotech, an ...
July 30, 2009 - The iso-omolar contrast medium iodixanol does not yield lower rates of contrast-induced acute kidney ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
July 1, 2009 — High doses, gadolinium-based MRI contrast agents alone are not sufficient to cause nephrogenic systemic ...
June 13, 2009 - Lantheus will be the first company to be able to offer Technetium-99 (Tc99m) derived from LEU to the U.S ...
June 12, 2009 - NanoScan Imaging LLC today announced the publication of new data demonstrating the use of its ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
June 12, 2009 - Covidien will be highlighting at the 2009 SNM Annual Conference in Toronto, June 13-17, its abbreviated ...
June 11, 2009 – PETNET Solutions, a subsidiary of Siemens Medical Solutions USA Inc. that manufactures and distributes ...
Molecular imaging in clinical trials accelerates the development of promising compounds by allowing physicians to see ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
June 2, 2009 - Celsense Inc. reported it is one of the recipients in a four-year $1.95 million grant from the National ...
May 28, 2009 - Lantheus Medical Imaging Inc. has completed patient enrollment of CaRES (Contrast Echocardiography ...
May 20, 2009 – Lantheus Medical Imaging Inc. has signed an agreement with NTP Radioisotopes (Pty) Ltd., a subsidiary of ...
May 8, 2009 – Siemens Healthcare has filed an exploratory Investigational New Drug (eIND) application with the FDA for a ...
The MEDRAD Informatics Solution platform uses a service-oriented architecture that automates capture of power injection ...
March 31, 2009 – Lantheus Medical Imaging Inc. reported that its novel fluorine 18-labeled positron emission tomography ...
March 30, 2009 – Lantheus Medical Imaging Inc. released at ACC 2009 new data regarding the use of DEFINITY Vial For ...
March 25, 2009 – Lantheus Medical Imaging Inc. today announced that new data for the company’s echocardiography contrast ...